Results 1 to 10 of about 372,210 (165)

Feasibility and acceptability of DMPA-SC self-injection in Addis Ababa, Ethiopia: a mixed-methods study [PDF]

Reproductive Health
Background Depot Medroxyprogesterone Acetate (DMPA) in a prefilled auto-disabled subcutaneous injectable contraceptive (Uniject™) can be administered by community health workers and clients.
Aderaw Anteneh, Megan M. Lydon, Katherine M. Anfinson, Fikreselassie Getachew, Erica Felker-Kantor, Tihut Mulugeta, Teferi Teklu, Rahel Demissew, Holly M. Burke   +8 more
doaj   +5 more sources

Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects [PDF]

Contraception, 2018
In 2015, private healthcare providers in Nigeria introduced DMPA-SC (depot medroxyprogesterone acetate administered subcutaneously) into the method mix. We aimed to [1] examine the sociodemographic predictors of continued DMPA-SC use after 3 months, and [2] characterize the additional influences of contraceptive counseling quality and experiences of ...
Jenny X Liu, Jennifer Shen, Nadia Diamond-Smith   +2 more
exaly   +10 more sources

Lessons from the scale-up of provider-administered and self-injection of DMPA-SC in Nigeria: a landscape assessment [PDF]

BMC Women's Health
Background Nigeria is the seventh-most populous country in the world. Its high fertility rate and unmet need for family planning contribute to the increasing population size.
Adewole A. Adefalu, Tolulope O. Afolaranmi, Ebony Fontenot, Rachel Simon, Miranda Buba, Victor Dafe, Funmilayo Olabode, Mary Ajayi, Olajimi Latunji, Joy M. Dogo   +9 more
doaj   +5 more sources

Scale-up of the DMPA-SC in Nigeria: Why policy matters [PDF]

BMC Women's Health, 2022
Background Injectable contraceptives have contributed substantially to Nigeria's rise in modern family planning methods usage. They are one of the most commonly used and preferred means of contraception among women in the country.
Oluwaseun Akinyemi, Nicole Danfakha, Adewole Adefalu, Ebony Easley, Kayode Afolabi, Olajimi Latunji   +5 more
doaj   +4 more sources

Perspectives on DMPA-SC for self-injection among adolescents with unmet need for contraception in Malawi [PDF]

Frontiers in Global Women's Health, 2023
IntroductionMalawi has made progress in expanding access to modern contraceptive methods over the last decade, including the introduction of depot-medroxyprogesterone acetate subcutaneous (DMPA-SC) in 2018.
Gracious Ali, Chelsey Porter Erlank, Frehiwot Birhanu, Melinda Stanley, Jessie Chirwa, Fannie Kachale, Andrews Gunda   +6 more
doaj   +4 more sources

DMPA-SC stock: Cross-site trends by facility type [PDF]

Contraception: X, 2022
To measure trends in the supply of DMPA-SC in public and private health facilities and compare with other prominent modern methods.We used repeated cross-sectional data from service-delivery-point surveys in six settings: Burkina Faso, Democratic Republic of Congo (Kinshasa and Kongo Central), Nigeria (Kano and Lagos), and Uganda, each with 3-5 rounds ...
Sophia Magalona, Shannon N Wood, Frederick Makumbi   +2 more
exaly   +5 more sources

Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi. [PDF]

PLOS Global Public Health, 2023
Since the introduction of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in 2018, Malawi has achieved national coverage of trained providers in the public sector and steady increases in uptake of DMPA-SC.
Chelsey Porter Erlank, Gracious Ali, Frehiwot Birhanu, Melinda Stanley, Jessie Salamba Chirwa, Fannie Kachale, Andrews Gunda   +6 more
doaj   +4 more sources

Setbacks in the road to self-injection: a descriptive study of provider and mystery client reports on the DMPA-SC care-seeking experience in Nigeria [PDF]

Frontiers in Global Women's Health
This mixed-methods study describes perspectives from health providers and simulated clients on initiation and continuation of DMPA-SC for self-injection in Nigeria.
Madeline Griffith, Sneha Challa, Ayobambo Jegede, Ivan Idiodi, Chioma Okoli, Aminat Tijani, Shakede Dimowo, Awawu Grace Nmadu, Elizabeth Omoluabi, Jenny Liu   +9 more
doaj   +4 more sources

Influence of Movement Restriction During the COVID-19 Pandemic on Uptake of DMPA-SC and Other Injectable Contraceptive Methods in Nigeria [PDF]

Open Access Journal of Contraception
Adewole Adebola Adefalu,1 Olufunke Abimbola Bankole,2 Funmilayo Olabode,2 Mojuba Bimbo Afolabi,2 Miranda Atare Buba,2 Victor Dafe,2 Mishael Nnanna Kalu,2 Emily Watkins3 1JSI Research & Training Institute, Inc., Atlanta, GA, USA; 2JSI Research & ...
Adefalu AA, Bankole OA, Olabode F, Afolabi MB, Buba MA, Dafe V, Kalu MN, Watkins E   +7 more
doaj   +5 more sources

Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal [PDF]

Contraception: X, 2019
To evaluate the cost-effectiveness of self-injected subcutaneous depot medroxyprogesterone acetate (DMPA-SC) compared to health-worker-administered intramuscular DMPA (DMPA-IM) in Senegal and to assess how including practice or demonstration injections in client self-injection training affects estimates.We developed a decision-tree model with a 12 ...
Mercy Mvundura, Jane Cover, Jennifer Kidwell Drake   +2 more
exaly   +5 more sources